Feasibility and usefulness of a fast-track clinic for patients suspected of polymyalgia rheumatica: notes for a work schedule through a narrative review of published literature.
fast-track clinic
narrative review
polymyalgia rheumatica
public health
Journal
Reumatologia
ISSN: 0034-6233
Titre abrégé: Reumatologia
Pays: Poland
ID NLM: 20130190R
Informations de publication
Date de publication:
2021
2021
Historique:
received:
13
07
2021
accepted:
11
10
2021
entrez:
25
11
2021
pubmed:
26
11
2021
medline:
26
11
2021
Statut:
ppublish
Résumé
Fast-track clinics (FTC) have been introduced in different fields and have been reporting significant outcomes in terms of reducing mortality, morbidity, and financial costs. To date, scarce evidence is available for FTC specific for patients suspected of polymyalgia rheumatica (PMR). The primary aim of our paper is to provide an overview of the clinical impact of PMR on patients and the healthcare system by analysing multiple aspects: the median time from onset of symptoms to diagnosis and the burden of the disease both on the healthcare system costs and on patients' quality of life (QoL). Secondarily, based on these data, we aim to discuss the potential advantages and feasibility of a PMR FTC in everyday clinical practice. We performed a narrative non-systematic review (PRISMA protocol not followed) of PubMed and Medline (OVID interface) with the following MeSH terms: [polymyalgia rheumatica AND diagnosis OR diagnosis, delayed OR patient care OR early diagnosis OR length of stay OR costs OR healthcare system OR quality of life] or [polymyalgia rheumatica AND glucocorticoids AND side effects]. We decided to exclude every paper that did not report raw data in terms of diagnostic time or delay, hospitalization rate, socio-economic costs on the healthcare system, patients' QoL, and glucocorticoids-related events in PMR patients. Papers focused primarily on giant cell arteritis patients with overlapping PMR were also excluded. Abstract archives of the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) congresses of the last 10 years were screened and included in the search if raw data were available. Each paper's reference list was scanned for additional publications meeting this study's aims. When papers reported data partially presented in previous articles, we opted to use the most recently published data. According to our literature review, a PMR FTC might lighten the burden of the disease. Nevertheless, its feasibility depends mostly on the resources of the national health system and of the territorial health district, which are heterogeneously limited. The usefulness of PMR FTCs depends on closer collaboration with the general practitioner because he/she is the first clinician to visit patients with PMR. Polymyalgia rheumatica fast-track clinics might lighten the burden of the disease. However, it has some limits that should carefully assessed in planning health policies.
Identifiants
pubmed: 34819707
doi: 10.5114/reum.2021.110600
pii: 45598
pmc: PMC8609375
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
323-329Informations de copyright
Copyright: © 2021 Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Korean Med Sci. 2018 Aug 10;33(36):e241
pubmed: 30181732
Recenti Prog Med. 2017 May;108(5):221-231
pubmed: 28643813
J Korean Med Sci. 2012 Jan;27(1):22-6
pubmed: 22219609
Cerebrovasc Dis. 2011;32(5):497-503
pubmed: 22057203
Rheumatol Int. 2017 Jan;37(1):143-149
pubmed: 27577940
Front Med (Lausanne). 2020 Dec 08;7:589794
pubmed: 33364248
J Clin Med. 2020 Dec 04;9(12):
pubmed: 33291857
Reumatol Clin. 2011 May-Jun;7(3):156-60
pubmed: 21794806
PLoS One. 2015 May 08;10(5):e0126758
pubmed: 25955770
CMAJ. 2019 Jun 24;191(25):E680-E688
pubmed: 31235489
Reumatismo. 2018 Mar 27;70(1):44-50
pubmed: 29589402
Reumatologia. 2020;58(6):381-389
pubmed: 33456081
Arthritis Care Res (Hoboken). 2018 Apr;70(4):643-647
pubmed: 28704600
Arthritis Care Res (Hoboken). 2019 Aug;71(8):1127-1131
pubmed: 30156754
Reumatismo. 2021 Jan 18;72(4):207-212
pubmed: 33677947
Open Access Rheumatol. 2016 Oct 17;8:93-95
pubmed: 27843375
Curr Rheumatol Rep. 2021 Feb 10;23(3):17
pubmed: 33569633
Rheumatol Int. 2013 Jun;33(6):1475-80
pubmed: 23184033
J Rheumatol. 2012 Mar;39(3):552-7
pubmed: 22247343
ACR Open Rheumatol. 2021 Mar;3(3):147-153
pubmed: 33570829
Clin Exp Rheumatol. 2015 Mar-Apr;33(2 Suppl 89):S-103-6
pubmed: 26016758
Ann Rheum Dis. 2015 Oct;74(10):1799-807
pubmed: 26359488
Arthritis Rheum. 2007 Mar 15;57(2):279-86
pubmed: 17330277
Medicines (Basel). 2018 Aug 01;5(3):
pubmed: 30071590
Sci Rep. 2021 Mar 18;11(1):6220
pubmed: 33737697
Reumatologia. 2020;58(4):196-201
pubmed: 32921825
Arthritis Rheum. 2005 Aug 15;53(4):578-84
pubmed: 16082650
Rheumatology (Oxford). 2019 May 1;58(5):921-923
pubmed: 30649507
Ann Rheum Dis. 2012 Apr;71(4):484-92
pubmed: 22388996
Reumatologia. 2018;56(1):1-2
pubmed: 29686435
Drugs Aging. 2019 Nov;36(11):1015-1026
pubmed: 31493201
Lancet. 2017 Oct 7;390(10103):1700-1712
pubmed: 28774422
Reumatologia. 2018;56(3):131-139
pubmed: 30042600
Semin Arthritis Rheum. 2020 Oct;50(5):1131-1139
pubmed: 32920326
BMC Musculoskelet Disord. 2011 May 14;12(1):94
pubmed: 21569559
Clin Exp Rheumatol. 2021 Jan-Feb;39(1):32-37
pubmed: 32242804
Clin Exp Rheumatol. 2021 May-Jun;39(3):564-569
pubmed: 33822703
Indian J Med Res. 2017 May;145(5):593-600
pubmed: 28948949
Rheumatol Int. 2014 Nov;34(11):1589-92
pubmed: 24816791
Clin Rheumatol. 2018 Jun;37(6):1633-1638
pubmed: 28573368
Joint Bone Spine. 2021 Oct;88(5):105185
pubmed: 33887471
Rheumatology (Oxford). 2016 Jan;55(1):66-70
pubmed: 26286743
Med Sci (Basel). 2019 Aug 30;7(9):
pubmed: 31480261